Chapter title |
Psychosocial Impact of Personalized Therapies in Oncology
|
---|---|
Chapter number | 11 |
Book title |
Psycho-Oncology
|
Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2018
|
DOI | 10.1007/978-3-319-64310-6_11 |
Pubmed ID | |
Book ISBNs |
978-3-31-964309-0, 978-3-31-964310-6
|
Authors |
Georgia Schilling, Frank Schulz-Kindermann |
Abstract |
Personalized medicine is a keyword in modern oncology summarizing biomarker-driven targeted therapies. Those novel agents enhance our therapeutic portfolio and offer new options for our patients. But the term is often misleading and implicates a tailored therapy to the individual person, but it rather means a treatment stratified on genetic characteristics of the tumor. Molecular therapies raise expectations of curability or long-term treatments making former life-threatening diseases to more chronic ones but this is true only for some patients. So we have to carefully communicate with our patients about the options and limitations of those modern therapies not to trigger disappointments. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 10 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Lecturer > Senior Lecturer | 1 | 10% |
Lecturer | 1 | 10% |
Student > Ph. D. Student | 1 | 10% |
Student > Master | 1 | 10% |
Researcher | 1 | 10% |
Other | 0 | 0% |
Unknown | 5 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Social Sciences | 2 | 20% |
Nursing and Health Professions | 1 | 10% |
Psychology | 1 | 10% |
Materials Science | 1 | 10% |
Unknown | 5 | 50% |